Anesth Pain Med.  2013 Jan;8(1):21-25.

A comparison of fentanyl and morphine for patient controlled analgesia after laparoscopic cholecystectomy

Affiliations
  • 1Department of Anesthesiology and Pain Medicine, Kosin University College of Medicine, Busan, Korea. kds0728md@gmail.com

Abstract

BACKGROUND
Intravenous patient controlled analgesia (IV-PCA) is a most common used delivery system for intravenous administration of opioids during acute post operative pain management. The objective of this study is to compare the rate of opioid induced adverse reactions and effectiveness among two IV-PCA opioids, morphine, fentanyl, in laparoscopic cholecystectomy pain management.
METHODS
Sixty patients in ASA physical status 1 and 2 scheduled for laparoscopic cholecystectomy were allocated randomly to either morphine IV-PCA used (n = 30, Group M) group or fentanyl IV-PCA used (n = 30, Group F) group. In each group, numerical rating scale (NRS) score, sedation score and incidence of side effect were checked.
RESULTS
NRS score of Group F showed lower than that of Group M during PACU and 3 hrs after the recovery room (P < 0.05). There were no significant differences in sedation score among two groups. The incidences of adverse reactions were similar in the two groups, though the incidence of nausea and pruritus were higher in the Group M.
CONCLUSIONS
Fentanyl IV-PCA is more advantageous than morphine IV-PCA for laparoscopic cholecystectomy in view of early pain control and adverse reaction incidences.

Keyword

Fentanyl; Laparoscopic cholecystectomy; Morphine; Opioid induced adverse reactions; Patient controlled analgesia

MeSH Terms

Administration, Intravenous
Analgesia, Patient-Controlled
Analgesics, Opioid
Cholecystectomy, Laparoscopic
Fentanyl
Humans
Incidence
Morphine
Nausea
Pain Management
Pruritus
Recovery Room
Analgesics, Opioid
Fentanyl
Morphine
Full Text Links
  • APM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr